Transition from a simple to a more advanced dose calculation algorithm for radiotherapy of non-small cell lung cancer (NSCLC): implications for clinical implementation in an individualized dose-escalation protocol.
暂无分享,去创建一个
P. Lambin | A. Dekker | L. Boersma | W. V. Elmpt | M. Velders | D. Ruysscher | B. Mijnheer | M. Ollers | K. Poels
[1] P. Lambin,et al. Individualized radical radiotherapy of non-small-cell lung cancer based on normal tissue dose constraints: a feasibility study. , 2008, International journal of radiation oncology, biology, physics.
[2] J. Conway,et al. Clinical implications of the anisotropic analytical algorithm for IMRT treatment planning and verification. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[3] Luca Cozzi,et al. On the dosimetric behaviour of photon dose calculation algorithms in the presence of simple geometric heterogeneities: comparison with Monte Carlo calculations , 2007, Physics in medicine and biology.
[4] Luca Cozzi,et al. Comparison of dose calculation algorithms for treatment planning in external photon beam therapy for clinical situations , 2006, Physics in medicine and biology.
[5] J. Lebesque,et al. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. , 2006, International journal of radiation oncology, biology, physics.
[6] Randall K Ten Haken,et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis. , 2006, International journal of radiation oncology, biology, physics.
[7] Philippe Lambin,et al. A Monte Carlo based three-dimensional dose reconstruction method derived from portal dose images. , 2006, Medical physics.
[8] R. T. Ten Haken,et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study. , 2005, International journal of radiation oncology, biology, physics.
[9] Joos V Lebesque,et al. Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer. , 2005, International journal of radiation oncology, biology, physics.
[10] Jeffrey Bradley,et al. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. , 2005, International journal of radiation oncology, biology, physics.
[11] John D Fenwick,et al. A challenge to traditional radiation oncology. , 2004, International Journal of Radiation Oncology, Biology, Physics.
[12] M. Socinski,et al. Carboplatin/Paclitaxel or Carboplatin/Vinorelbine Followed by Accelerated Hyperfractionated Conformal Radiation Therapy: Report of a Prospective Phase I Dose Escalation Trial From the Carolina Conformal Therapy Consortium , 2004 .
[13] Andrew Jackson,et al. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. , 2004, International journal of radiation oncology, biology, physics.
[14] A Nisbet,et al. The clinical implications of the collapsed cone planning algorithm. , 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).
[15] Joos V Lebesque,et al. Incorporating an improved dose-calculation algorithm in conformal radiotherapy of lung cancer: re-evaluation of dose in normal lung tissue. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[16] Christian Scholz,et al. Development and clinical application of a fast superposition algorithm in radiation therapy. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[17] Feliciano García-Vicente,et al. Experimental validation tests of fast Fourier transform convolution and multigrid superposition algorithms for dose calculation in low-density media. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[18] M van Herk,et al. Field size reduction enables iso-NTCP escalation of tumor control probability for irradiation of lung tumors. , 2001, International journal of radiation oncology, biology, physics.
[19] M. Socinski,et al. Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: report of a prospective phase I dose escalation trial from the Carolina Conformal Therapy Consortium. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] M Engelsman,et al. Impact of simple tissue inhomogeneity correction algorithms on conformal radiotherapy of lung tumours. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[21] M Miften,et al. Implementation of FFT convolution and multigrid superposition models in the FOCUS RTP system. , 2000, Physics in medicine and biology.
[22] R K Ten Haken,et al. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. , 1998, International journal of radiation oncology, biology, physics.
[23] S Webb,et al. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. , 1993, Physics in medicine and biology.
[24] Tommy Knöös,et al. Clinical implications of the implementation of advanced treatment planning algorithms for thoracic treatments. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[25] Philippe Lambin,et al. The next step in patient-specific QA: 3D dose verification of conformal and intensity-modulated RT based on EPID dosimetry and Monte Carlo dose calculations. , 2008, Radiotherapy and Oncology.
[26] P. Lambin,et al. Treatment verification in the presence of inhomogeneities using EPID-based three-dimensional dose reconstruction. , 2007, Medical physics.
[27] Thomas Krieger,et al. Influence of calculation model on dose distribution in stereotactic radiotherapy for pulmonary targets. , 2005, International journal of radiation oncology, biology, physics.
[28] A. Boyer,et al. Tissue Inhomogeneity Corrections for Megavoltage Photon Beams , 2004 .
[29] R Mackie,et al. A new approach to dose escalation in non-small-cell lung cancer. , 2001, International journal of radiation oncology, biology, physics.
[30] R K Ten Haken,et al. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] A. Niemierko. Reporting and analyzing dose distributions: a concept of equivalent uniform dose. , 1997, Medical physics.